Intergalactic Therapeutics (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- October 07, 2021
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $75,000,000
Company Info
- Founders
- Michael Ehlers, M.D., Ph.D.
- Company Description
- Intergalactic Therapeutics, an ATP company, is revolutionizing gene therapies with a novel non-viral platform comprised of its versatile synthetic and episomal C3DNA (covalently closed and circular DNA) molecules; a customized approach to focal therapeutic delivery using its lead delivery technology, the COMET® pulsed electric field system; and a proprietary cell-free manufacturing process invented to make gene therapy safer and more accessible for patients.
- Market
- Gene Therapy
- Location
- Boston, MA, USA